GOTHENBURG, Sweden, March 7, 2025 /PRNewswire/ — Minesto, leading ocean energy developer, has been selected to participate in GIA (Global Innovation Accelerator). The Global Innovations Accelerator Programme is initiated and funded by the Swedish Energy Agency, and run together with partner Business Sweden. Minesto’s focus will be on strengthening business development in Asia.

Swedish Energy Agency describes the Global Innovation Accelerator as a tailor-made accelerator for companies that contribute to the Swedish and global transition towards a sustainable energy system and have an established international market strategy. A program round lasts around 12 to 18 months and focuses on business and market development support. GIA programme entails for example market mapping, support for standardization and certification issues, participation in conference or trade fair, and investor search.

CONTACT: For additional information, please contactCecilia Sernhage, Chief Communications Officer+46 735 23 71 58ir@minesto.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/minesto-ab/r/minesto-selected-to-participate-in-gia–global-innovation-accelerator–programme-by-swedish-energy-a,c4116146

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Industrial Flow Solutions Assumes Full Manufacturing Operations of Its Proprietary OverWatch® Direct In-Line Pump Products

NEW HAVEN, Conn. and MONSELICE, Italy, July 20, 2026 /PRNewswire/ — Industrial Flow…

Midea Showcases Breakthrough Cooling Technologies for High-Density AI Data Centers at Data Center World Asia 2026

SINGAPORE, Oct. 2, 2026 /PRNewswire/ — The Asia Data Centre World 2026…

Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress

SHANGHAI, Oct. 15, 2025 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company…